National trial safely scales back prescribing of a powerful antipsychotic for the elderly
Warning letters from Medicare can safely cut prescribing of a powerful but risky antipsychotic, according to a new study at Columbia University Mailman School of Public Health. Researchers used Medicare data to study the ...
Apr 25, 2024
0
0